Table 2. Incidence (and percentage) of human serum IgM and IgG antibodies binding to pRBCs and pAECs.
Target cells | IgM Incidence (%) | IgG Incidence (%) |
---|---|---|
pRBCs | Anti-nonGal | Anti-nonGal |
63/84 (75%) | 55/84 (66%) | |
Anti-nonGal/nonNeuGc | Anti-nonGal/nonNeuGc | |
19/84 (23%) | 12/84 (14%) | |
pAECs | Anti-nonGal | Anti-nonGal |
84/84 (100%) | 84/84 (100%) | |
Anti-nonGal/nonNeuGc | Anti-nonGal/nonNeuGc | |
82/84 (98%) | 80/84 (95%) |